Literature DB >> 1360226

Beyond the mega-trial: certainty and uncertainty.

J R Hampton1, A M Skene.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1360226      PMCID： PMC1025131          DOI： 10.1136/hrt.68.10.352

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  8 in total

1.  Application of Bayesian statistics to decision making during a clinical trial.

Authors:  L S Freedman; D J Spiegelhalter
Journal:  Stat Med       Date:  1992-01-15       Impact factor: 2.373

Review 2.  Planning and monitoring of equivalence studies.

Authors:  S Durrleman; R Simon
Journal:  Biometrics       Date:  1990-06       Impact factor: 2.571

3.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Authors:  J N Cohn; G Johnson; S Ziesche; F Cobb; G Francis; F Tristani; R Smith; W B Dunkman; H Loeb; M Wong
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

4.  Should every survivor of a heart attack be given a beta-blocker? Part I. Evidence from clinical trials.

Authors:  J R Hampton
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-03

5.  Effect of propranolol in myocardial infarction.

Authors:  P J Snow
Journal:  Lancet       Date:  1965-09-18       Impact factor: 79.321

6.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

Authors:  M H Frick; O Elo; K Haapa; O P Heinonen; P Heinsalmi; P Helo; J K Huttunen; P Kaitaniemi; P Koskinen; V Manninen
Journal:  N Engl J Med       Date:  1987-11-12       Impact factor: 91.245

7.  Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial.

Authors:  A Hjalmarson; D Elmfeldt; J Herlitz; S Holmberg; I Málek; G Nyberg; L Rydén; K Swedberg; A Vedin; F Waagstein; A Waldenström; J Waldenström; H Wedel; L Wilhelmsen; C Wilhelmsson
Journal:  Lancet       Date:  1981-10-17       Impact factor: 79.321

8.  A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction.

Authors:  P C Elwood; A L Cochrane; M L Burr; P M Sweetnam; G Williams; E Welsby; S J Hughes; R Renton
Journal:  Br Med J       Date:  1974-03-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.